Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Fever, a hallmark of disease, is elicited by exogenous pyrogens, that is, cellular components, such as lipopolysaccharide (LPS), of infectious organisms, as well as by non-infectious inflammatory insults. Both stimulate the production of cytokines, such as interleukin (IL)-1beta, that act on the brain as endogenous pyrogens. Fever can be suppressed by aspirin-like anti-inflammatory drugs. As these drugs share the ability to inhibit prostaglandin biosynthesis, it is thought that a prostaglandin is important in fever generation. Prostaglandin E2 (PGE2) may be a neural mediator of fever, but this has been much debated. PGE2 acts by interacting with four subtypes of PGE receptor, the EP1, EP2, EP3 and EP4 receptors. Here we generate mice lacking each of these receptors by homologous recombination. Only mice lacking the EP3 receptor fail to show a febrile response to PGE2 and to either IL-1beta or LPS. Our results establish that PGE2 mediates fever generation in response to both exogenous and endogenous pyrogens by acting at the EP3 receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice lacking the PGE 2 receptor EP3 [112] or microsomal prostaglandin E synthase-1 enzyme [121,122] were shown to have impaired febrile responses.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [121]
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Fever: Role of Pyrogens and Cryogens
Kluger, M. J. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.93 · Cited by 1,215
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
Self-citationAltered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773 · cited 1×
“Mice lacking the EP 1 or EP 3 receptors were generated nearly as describe”
MethodSelf-citationFailure of Parturition in Mice Lacking the Prostaglandin F Receptor
Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., et al. (1997) · Science · doi:10.1126/science.277.5326.681 · Cited by 608
Self-citationKiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., & Narumiya, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701367 · Cited by 510
Self-citationMeng, F., & Lowell, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1661 · Cited by 479
Flier, J. S., Underhill, L. H., Saper, C. B., & Breder, C. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302609 · Cited by 374
Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice
Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K. J., Corn, C. A., Soszynski, D., Grabiec, C., Trumbauer, M. E., Shaw, A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90154-x · Cited by 365
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
Nguyen, M., Camenisch, T., Snouwaert, J. N., Hicks, E., Coffman, T. M., Anderson, P. A. W., Malouf, N. N., & Koller, B. H. (1997) · Nature · doi:10.1038/36342 · Cited by 363
Cited by
Items 101–200 of 682
Prostanoid receptor antagonists: development strategies and therapeutic applications
Jones, R., Giembycz, M. A., & Woodward, D. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00317.x · Cited by 172
Cytokines, PGE2 and endotoxic fever: a re-assessment
Blatteis, C. M., Li, S., Li, Z., Feleder, C., & Perlík, V. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.01.001 · Cited by 177
Lee, H.-C., Inoue, T., Sasaki, J., Kubo, T., Matsuda, S., Nakasaki, Y., Hattori, M., Tanaka, F., Udagawa, O., Kono, N., et al. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-09-0673 · Cited by 151
“enzymes such as cPLA2α, MAGL and 5-LOX, or knockout of the receptors for prostaglandins and leukotrienes such as PGE2 receptors do not show phenotypes similar to those of Lpiat1 mice (Uozumi et al., 1997; Bonventre et al., 1997; Chen et al., 1994; Ushikubi et al., 1998).”
BackgroundProstaglandin E2-synthesizing enzymes in fever: differential transcriptional regulation
Ivanov, A. I., Pero, R. S., Scheck, A. C., & Romanovsky, A. A. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00347.2002 · Cited by 152
“Vagal sensory neurons express PG receptors of the EP3 type (19), and the phase I of LPS fever does not occur in EP3 or EP1 receptor knockout mice (48, 80).”
Ikemoto, A., Ohishi, M., Sato, Y., Hata, N., Misawa, Y., Fujii, Y., & Okuyama, H. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32220-3 · Cited by 150
Oka, T., Oka, K., Scammell, T. E., Lee, C., Kelly, J. F., Nantel, F., Elmquist, J. K., & Saper, C. B. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001204)428:1<20::aid-cne3>3.0.co;2-x · Cited by 150
Angle, S. R., Sena, K., Sumner, D. R., & Virdi, A. S. (2010) · Ultrasonics · doi:10.1016/j.ultras.2010.09.004 · Cited by 155
“PGE2 acts as an endogenous mediator in osteogenesis [68,69].”
Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia
Takayama, K., Yuhki, K., Ono, K., Fujino, T., Hara, A., Yamada, T., Kuriyama, S., Karibe, H., Okada, Y., Takahata, O., et al. (2005) · Nature Medicine · doi:10.1038/nm1231 · Cited by 152
“In addition, a pattern of tachycardia in response to LPS in mice lacking EP 3 , which showed a defective febrile response to LP”
BackgroundSelf-citationLipid Mediators in Life Science
MURAKAMI, M. (2011) · Experimental Animals · doi:10.1538/expanim.60.7 · Cited by 147
“EP3 [13, 39, 86].”
Diversification of Cyclooxygenase-2-Derived Prostaglandins in Ovulation and Implantation1
Matsumoto, H., Ma, W., Smalley, W., Trzăskos, J. M., BREYER, R. M., & Dey, S. K. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.5.1557 · Cited by 148
“However, results of gene-targeting experiments have shown that EP1- and EP3-deficient female mice have normal fertility, suggesting their nonessential roles in ovulation, fertilization, and implantation [11].”
BackgroundFever and hypothermia in systemic inflammation
Garami, A., Steiner, A. A., & Romanovsky, A. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00034-3 · Cited by 170
Long-Term Alterations in Neuroimmune Responses after Neonatal Exposure to Lipopolysaccharide
Boissé, L., Mouihate, A., Ellis, S., & Pittman, Q. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1077-04.2004 · Cited by 142
“, 1995) and EP (Ushikubi et al., 1998; Nakamura et al., 2000) receptors thought to be involved in fever.”
BackgroundBehavioral fever in ectothermic vertebrates
Rakus, K. Ł., Ronsmans, M., & Vanderplasschen, A. F. C. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.06.027 · Cited by 162
“Four subtypes of PGE2 receptors have been described, namely EP1-EP4 (Oka, 2004), among which EP3 was shown to be critical in the induction of fever (Lazarus et al., 2007; Saper et al., 2012; Ushikubi et al., 1998).”
Hanada, R., Hanada, T., Sigl, V., Schramek, D., & Penninger, J. M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0749-z · Cited by 154
“Importantly, central RANKL injection into prostaglandin EP3 receptor knock-out mice [83], which is responsible for the thermoregulatory function of prostaglandin E2 (PGE2), did not trigger fever or circadian activities.”
BackgroundTakahashi, T., Morrow, J. D., Wang, H., & Dey, S. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608202200 · Cited by 140
Hirata, T., & Narumiya, S. (2011) · Chemical Reviews · doi:10.1021/cr200010h · Cited by 148
Self-citationBosetti, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04558.x · Cited by 136
“EP3 receptors, but not the other subtypes of EP receptors, play important roles in mediating the febrile response after injection of PGE2, interleukin-1b, or LPS (Ushikubi et al. 1998), by generating hyperthermia (Lazarus 2006).”
BackgroundInfluentialProstaglandins and sickness behavior: Old story, new insights
Pecchi, E., Dallaporta, M., Jean, A., Thirion, S., & Troadec, J.-D. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.040 · Cited by 135
“EP1, EP2 and EP4, andwild-type animals, exhibit a similar increase in temperature [109].”
BackgroundMolecular signaling in uterine receptivity for implantation
Paria, B. C., Lim, H. J., Das, S. K., Reese, J., & Dey, S. K. (2000) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0153 · Cited by 157
Madden, C. J., & Morrison, S. F. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00515.2003 · Cited by 135
“Furthermore, the prostaglandin EP3 receptor is found in the MPA (10, 19, 22) and EP3 receptor knockout mice have an impaired febrile response to systemic pyrogen administration (30).”
Activation of IκB Kinase by Herpes Simplex Virus Type 1
Amici, C., Belardo, G., Rossi, A., & Santoro, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103408200 · Cited by 135
Tanaka, K., Furuyashiki, T., Kitaoka, S., Senzai, Y., Imoto, Y., Segi-Nishida, E., Deguchi, Y., Breyer, R. M., Breyer, M. D., & Narumiya, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5952-11.2012 · Cited by 131
“EP1-, EP2-, and EP3-deficient mice were generated and backcrossed more than 10 generations to the C57BL/6N background (Ushikubi et al., 1998; Hizaki et al., 1999; Matsuoka et al., 2005).”
BackgroundSelf-citationProstaglandin E2–EP3 Signaling Induces Inflammatory Swelling by Mast Cell Activation
Morimoto, K., Shirata, N., Taketomi, Y., Tsuchiya, S., Segi-Nishida, E., Inazumi, T., Kabashima, K., Tanaka, S., Murakami, M., Narumiya, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300290 · Cited by 132
Self-citationStress responses: the contribution of prostaglandin E2 and its receptors
Furuyashiki, T., & Narumiya, S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.194 · Cited by 139
Self-citationTargeting innate immunity for neurodegenerative disorders of the central nervous system
Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., Landreth, G., Lee, D. C., Low, D., Lynch, M. A., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13667 · Cited by 126
Prostaglandin E receptor EP1 controls impulsive behavior under stress
Matsuoka, Y., Furuyashiki, T., Yamada, K., Nagai, T., Bito, H., Tanaka, Y., Kitaoka, S., Ushikubi, F., Nabeshima, T., & Narumiya, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504908102 · Cited by 123
Self-citationA hypothalamomedullary network for physiological responses to environmental stresses
Nakamura, K., Nakamura, Y., & Kataoka, N. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00532-x · Cited by 135
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Narumiya, S., Sügimura, T., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00440-7 · Cited by 120
Self-citationBoulet, L., Ouellet, M., Bateman, K. P., Ethier, D., Percival, M. D., Riendeau, D., Mancini, J. A., & Méthot, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400443200 · Cited by 120
Pyrogen Sensing and Signaling: Old Views and New Concepts
Blatteis, C. M., Sehic, E., & Li, S. (2000) · Clinical Infectious Diseases · doi:10.1086/317522 · Cited by 120
“It could thus bind to its receptors (EP3 R) [46] in the immediate vicinity of its”
BackgroundFujino, T., Nakagawa, N., Yuhki, K., Hara, A., Yamada, T., Takayama, K., Kuriyama, S., Hosoki, Y., Takahata, O., Taniguchi, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21382 · Cited by 114
Self-citationTakeuchi, K., Ukawa, H., Kato, S., Furukawa, O., Araki, H., Sugimoto, Y., ICHIKAWA, A., Ushikubi, F., & Narumiya, S. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70398-7 · Cited by 117
Self-citationDual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitis
Esaki, Y., Li, Y., Sakata, D., Yao, C., Segi-Nishida, E., Matsuoka, T., Fukuda, K., & Narumiya, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915112107 · Cited by 113
Self-citationG-protein-coupled receptor expression, function, and signaling in macrophages
Lattin, J., Zidar, D. A., Schroder, K., Kellie, S., Hume, D. A., & Sweet, M. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107051 · Cited by 113
“[142–149].”
Prostanoids as Regulators of Innate and Adaptive Immunity
Hirata, T., & Narumiya, S. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00005-3 · Cited by 126
Self-citationProstaglandin Receptor Signaling in Disease
Matsuoka, T., & Narumiya, S. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.182 · Cited by 115
“Ushikubi et al.[36] clarified a crucial role of EP3, but not EP1 or EP4, in fever generation by showing that EP3–/– mice fail to respond to either exogenous or endogenous pyrogens.”
BackgroundSelf-citationMatsuoka, Y., Furuyashiki, T., Bito, H., Ushikubi, F., Tanaka, Y., Kobayashi, T., Muro, S., Satoh, N., Kayahara, T., Higashi, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0633341100 · Cited by 110
Self-citationMa, H., Hara, A., Xiao, C. Y., Okada, Y., Takahata, O., Nakaya, K., Sugimoto, Y., Ichikawa, A., Narumiya, S., & Ushikubi, F. (2001) · Circulation · doi:10.1161/hc3601.094003 · Cited by 110
Self-citationGating and the Need for Sleep: Dissociable Effects of Adenosine A1 and A2A Receptors
Lazarus, M., Oishi, Y., Bjorness, T. E., & Greene, R. W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00740 · Cited by 108
“, 2011)] and prostaglandins (Ushikubi et al., 1998; Lazarus et al., 2007; Urade and Lazarus, 2013; Oishi et al., 2015) [for review, see (Urade and Lazarus, 2013)], are interrelated with the regulation of sleep.”
BackgroundEicosanoid Actions in Insect Immunity
STANLEY, D. W., Miller, J. D., & Tunaz, H. (2009) · Journal of Innate Immunity · doi:10.1159/000210371 · Cited by 109
“The cellular actions mediated by these receptors influence homeostatic physiology, such as induction of fever [”
BackgroundSaha, S., Engström, L., Mackerlova, L., Jakobsson, P.-J., & Blomqvist, A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00872.2004 · Cited by 108
“The EP3 receptor seems to be critical for the febrile response, since mice with a deletion of the EP3 receptor gene do not develop fever in response to subcutaneous turpentine or to systemic or intraperitoneal injection of lipopolysaccharide or IL-1 (39, 53), and they are also unresponsive to intracerebrally delivered…”
BackgroundResultTurrin, N. P., & Rivest, S. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901003 · Cited by 107
Wilhelms, D., Kirilov, M., Mirrasekhian, E., Eskilsson, A., Kugelberg, U. Ö., Klar, C., Ridder, D. A., Herschman, H. R., Schwaninger, M., Blomqvist, A. G., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1838-14.2014 · Cited by 110
“Furthermore, selective interventions with prostaglandin E2 (PGE2) synthesis (Engblom et al., 2003) or its receptor binding (Ushikubi et al., 1998; Lazarus et al., 2007) block fever.”
BackgroundInteractions Between the Immune and Neuroendocrine Systems
Rivest, S. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81004-7 · Cited by 108
Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice
de Paiva, V. N., Lima, S. N. P., Fernandes, M. M., Soncini, R., Andrade, C. A. F., & Giusti-Paiva, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.07.015 · Cited by 104
Madden, C. J., & Morrison, S. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00527-x · Cited by 107
Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration.
Hopkins, S. J. (2007) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 127
Zhang, Y., Lu, J., Elmquist, J. K., & Saper, C. B. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10743 · Cited by 102
“However the EP4 receptors seem not to be involved in producing fever responses (Ushikubi et al., 1998; Oka et al., 2003).”
BackgroundStimulation of renin release by prostaglandin E2is mediated by EP2and EP4receptors in mouse kidneys
Schweda, F., Klar, J., Narumiya, S., Nüsing, R. M., & Kurtz, A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2004 · Cited by 101
“Genotypes of the mice were routinely determined by PCR analysis using oligonucleotide primers designed to detect the respective EP locus and Neo cassette, as reported earlier (14, 26, 31).”
MethodSelf-citationHara, A., Yuhki, K., Fujino, T., Yamada, T., Takayama, K., Kuriyama, S., Takahata, O., Karibe, H., Okada, Y., Xiao, C.-Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.527077 · Cited by 103
Self-citationPPARδ Functions as a Prostacyclin Receptor in Blastocyst Implantation
Lim, H. J., & Dey, S. K. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00243-5 · Cited by 108
Prostaglandin receptors: their role in regulating renal function
Breyer, M. D., & BREYER, R. M. (2000) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200001000-00005 · Cited by 101
Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors
Kabashima, K., Nagamachi, M., Honda, T., Nishigori, C., Miyachi, Y., TOKURA, Y., & Narumiya, S. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700491 · Cited by 109
“4 We have previously generated mice individually deficient in each of the four subtypes of PGE 2 receptors and studied the in vivo significance of each PGE 2 receptor with novel findings in various aspects”
MethodSelf-citationNonsteroidal Anti-Inflammatory Drugs, Acetaminophen, Cyclooxygenase 2, and Fever
Simmons, D. L., Wagner, D., & Westover, K. (2000) · Clinical Infectious Diseases · doi:10.1086/317517 · Cited by 99
“Similarly, mice that lacked the PGE2-EP3 receptors were unable to develop a normal febrile response to either an exogenous or an endogenous pyrogenic challenge [41].”
BackgroundMorrison, S. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00363-4 · Cited by 102
Kunikata, T., Tanaka, A., Miyazawa, T., Kato, S., & Takeuchi, K. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1014725024519 · Cited by 98
Analgesic strategies beyond the inhibition of cyclooxygenases
Zeilhofer, H. U., & Brune, K. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.007 · Cited by 110
COX‐2 and iNOS, good targets for chemoprevention of colon cancer
Watanabe, K., Kawamori, T., Nakatsugi, S., & Wakabayashi, K. (2000) · BioFactors · doi:10.1002/biof.5520120120 · Cited by 96
Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1
Nagamachi, M., Sakata, D., Kabashima, K., Furuyashiki, T., Murata, T., Segi‐Nishida, E., Soontrapa, K., Matsuoka, T., Miyachi, Y., & Narumiya, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070773 · Cited by 109
Self-citationYuhki, K., Kojima, F., Kashiwagi, H., Kawabe, J.-I., Fujino, T., Narumiya, S., & Ushikubi, F. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.004 · Cited by 106
Self-citationImmunocytochemical localization of prostaglandin EP3 receptor in the rat hypothalamus
Nakamura, K., Kaneko, T., Yamashita, Y., Hasegawa, H., Katoh, H., Ichikawa, A., & Negishi, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00962-8 · Cited by 95
Self-citationInflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease
Shi, J., Wang, Q., Johansson, J. U., Liang, X., Woodling, N. S., Priyam, P., Loui, T. M., Merchant, M., Breyer, R. M., Montine, T. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23677 · Cited by 92
Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages
Trebino, C. E., Eskra, J. D., Wachtmann, T. S., Perez, J. R., Carty, T. J., & Audoly, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412075200 · Cited by 93
Prostaglandin E2–EP3 signaling suppresses skin inflammation in murine contact hypersensitivity
Honda, T., Matsuoka, T., Ueta, M., Kabashima, K., Miyachi, Y., & Narumiya, S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.04.029 · Cited by 94
Self-citationLazarus, M., Chen, J., Huang, Z., Urade, Y., & Fredholm, B. B. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_36 · Cited by 110
Fever: Links with an ancient receptor
Dinarello, C. A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80085-2 · Cited by 91
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
SCHWARTZ, J., CHAN, C., MUKHOPADHYAY, S., MCBRIDE, K., JONES, T., ADCOCK, S., MORITZ, C., HEDGES, J., GRASING, K., & DOBRATZ, D. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90087-5 · Cited by 89
“Recent studies with mice engineered to lack the EP 3 -receptor have confirmed the critical role of PGE 2 in fever generation secondary to exogenous or endogenous pyrogens”
BackgroundProstanoid receptors: ontogeny and implications in vascular physiology
Wright, D. H., Abran, D., Bhattacharya, M., Hou, X., Bernier, S. G., Bouayad, A., Fouron, J., Vazquez‐Tello, A., Beauchamp, M., Clyman, R. I., et al. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.5.r1343 · Cited by 105
“There are three individual reports of the genetic disruption of the EP1 receptor gene (EP1) (16, 217, 225).”
BackgroundFever, Immunity, and Molecular Adaptations
Hasday, J. D., Thompson, C. M., & Singh, I. S. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130019 · Cited by 105
“…neurons also express a marker for GABAergic function (264) The febrile response to exogenous PGE 2 and LPS is absent in EP 3 -deficient mice (412) and in mice with tissue specific EP 3 deletion in MnPO neurons (203) but only partially attenuated in EP 1 receptor-deficient mice (286), further…”
EP3R-Expressing Glutamatergic Preoptic Neurons Mediate Inflammatory Fever
Machado, N. L. S., Bandaru, S. S., Abbott, S. B. G., & Saper, C. B. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2887-19.2020 · Cited by 86
“There are four different PGE2 receptors in the hypothalamus, but only deletion of the EP3 receptor, either in the whole body or in the brain (Ushikubi et al., 1998; Oka et al., 2003) or in the MnPO (Lazarus et al., 2007) prevents fever responses to intraventricular PGE2 or to intravenous LPS.”
BackgroundProstanoids and inflammation: a new concept arising from receptor knockout mice
Narumiya, S. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0500-1 · Cited by 88
“PGE2/EP3: mediates pleural exudation [3], fever generation [5], and peripheral hyperalgesia [7], negatively regulates allergic inflammation [22–24]”
BackgroundSelf-citationYoshida, K., Nakamura, K., Matsumura, K., Kanosue, K., König, M., Thiel, H., Boldogköi, Z., Toth, I., Roth, J., Gerstberger, R., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02919.x · Cited by 86
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Santiso, A., Heinemann, Á., & Kargl, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000901 · Cited by 104
Thermoeffector neuronal pathways in fever: a study in rats showing a new role of the locus coeruleus
Almeida, M. C., Steiner, A. A., Coimbra, N. C., & Branco, L. G. S. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066654 · Cited by 85
“By interacting with EP3 receptors (Ushikubi et al. 1998; Oka et al. 2003) and consequently decreasing the intracellular level of cyclic AMP in preoptic neurones (Steiner et al. 2002; Steiner & Branco, 2003), PGE2 triggers an appropriate thermoeffector response to increase T c.”
BackgroundFrom humoral fever to neuroimmunological control of fever
Zeisberger, E. (1999) · Journal of Thermal Biology · doi:10.1016/s0306-4565(99)00033-9 · Cited by 100
Non-steroid anti-inflammatory drugs, prostaglandins, and cancer
Allaj, V., Guo, C., & Nie, D. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-8 · Cited by 86
“Prostanoids usually act within the tissue, where they are synthesized, via a carrier-mediated process [8] to activate the membrane receptors [9-11], or in some cases may interact with nuclear receptors [12].”
Sympathetic premotor neurons mediating thermoregulatory functions
Nakamura, K., Matsumura, K., Kobayashi, S., & Kaneko, T. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.09.007 · Cited by 91
“, 1999, 2000), and analyses of mice lacking each of the PGE receptor subtypes showed that only EP3 receptor-deficient mice completely failed to show a febrile response to PGE2, interleukin-1b, or endotoxin (Ushikubi et al., 1998), although, in a later study, EP1 receptor-deficient ones showed a partial attenuation of…”
BackgroundProstaglandin E2 as a mediator of fever: the role of prostaglandin E (EP) receptors
Oka, T. (2004) · Frontiers in bioscience · doi:10.2741/1458 · Cited by 89
Stress-induced hyperthermia and hypothermia
Oka, T. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00035-5 · Cited by 100
Signaling the brain in systemic inflammation: the role of complement
Clark, M. B. (2004) · Frontiers in bioscience · doi:10.2741/1297 · Cited by 84
“we hypothesized that the peripheral fever trigger could be PGE2 released by Kc stimulated by LPS-activated C components and binding to EP receptors on sensory nerves (EP3 are expressed on sensory neurons and EP3 knockouts do not develop fever after iv LPS [50]; EP1 and EP4 receptors have also been implicated in the fe…”
BackgroundCOX-2-PGE2-EPs in gynecological cancers
Yao, Y., Wang, X., Jeschke, U., & von Schönfeldt, V. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05559-6 · Cited by 88
TAKEUCHI, K., Kato, S., ARAKI, H., Komoike, Y., & TAKEEDA, M. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)80669-7 · Cited by 78
Roles of Prostanoids Revealed From Studies Using Mice Lacking Specific Prostanoid Receptors
Ushikubi, F., Sugimoto, Y., Ichikawa, A., & Narumiya, S. (2000) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)30561-x · Cited by 78
Self-citationPharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
Carey, M. A., Bradbury, J. A., Rebolloso, Y. D., Graves, J. P., Zeldin, D. C., & Germolec, D. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011610 · Cited by 77
“PGE2 produces fever when injected intracerebroventricularly [27] and mice lacking the EP3 receptor also lacked an appropriate febrile response to PGE2 [28].”
BackgroundAraki, H., Ukawa, H., Sugawa, Y., Yagi, K., Suzuki, K., & Takeuchi, K. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.014s1116.x · Cited by 77
A Novel Antipyretic Action of 15-Deoxy-Δ12,14-Prostaglandin J2in the Rat Brain
Mouihate, A., Boissé, L., & Pittman, Q. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3145-03.2004 · Cited by 75
“We have found, however, that the hypothalamic expression of E-type prostaglandin receptor, a necessary receptor for fever development (Ushikubi et al., 1998), is stable after LPS treatment (Mouihate et al.”
BackgroundThermoregulation via Temperature-Dependent PGD2 Production in Mouse Preoptic Area
Wang, T. A., Teo, C. F., Åkerblom, M., Chen, C., Fontaine, M. T.-L., Greiner, V. J., Diaz, A. A., McManus, M. T., Jan, Y. N., & Jan, L. Y. (2019) · Neuron · doi:10.1016/j.neuron.2019.04.035 · Cited by 83
“05, One-way ANOVA), we tested for its effect in a fever model of hyperthermia induced by intracerebroventricular (ICV) injection of PGE2 (Ushikubi et al., 1998).”
InfluentialThe PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice
Ceddia, R. P., Lee, D., Maulis, M. F., Carboneau, B. A., Threadgill, D. W., Poffenberger, G., Milne, G., Boyd, K. L., Powers, A. C., McGuinness, O. P., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1693 · Cited by 75
“This report contrasts with a previous report that EP3 / mice have normal growth rates (23).”
ResultEP2receptors mediate airway relaxation to substance P, ATP, and PGE2
Fortner, C. N., BREYER, R. M., & Paul, R. J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l469 · Cited by 75
Miyamoto, M. R., Ito, H., Mukai, S., Kobayashi, T., Yamamoto, H., Kobayashi, M., Maruyama, T., Akiyama, H., & Nakamura, T. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(03)00118-3 · Cited by 75
Self-citationPhysiology and pathophysiology of prostanoid receptors
Narumiya, S. (2007) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.83.296 · Cited by 74
Self-citationKunz, T., Marklund, N., Hillered, L., & Oliw, E. H. (2002) · Journal of Neurotrauma · doi:10.1089/089771502760341965 · Cited by 78
“Mice deficient in COX-2 or the prostanoid receptor EP 3 show no fever response to pyrogens (Li et al., 1999; Ushikubi et al., 1998).”
Molecular Aspects of Fever and Hyperthermia
Roth, J., Rummel, C. D., Barth, S. W., Gerstberger, R., & Hübschle, T. (2006) · Neurologic Clinics · doi:10.1016/j.ncl.2006.03.004 · Cited by 88
Nava, C., Keren, B., Mignot, C., Rastetter, A., Chantot‐Bastaraud, S., Faudet, A., Fonteneau, E., Amiet, C., Laurent‐Levinson, C., Jacquette, A., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.88 · Cited by 78
Expression, localization and function of prostaglandin receptors in myometrium
Myatt, L., & Lye, S. J. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.004 · Cited by 73
Zhang, J., & Rivest, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742134.x · Cited by 73
“, 1997) as well as fever generation in response to both exogenous and endogenous pyrogens (Ushikubi et al., 1998).”
BackgroundFritz, M., Klawonn, A. M., Nilsson, A., Singh, A. K., Zajdel, J., Björk Wilhelms, D., Lazarus, M., Löfberg, A., Jaarola, M., Örtegren Kugelberg, U., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83844 · Cited by 72
“This resulted in mice with EP1Rs expressed only in cells expressing the dopamine D1R.”
BackgroundInfluentialClinical chorioamnionitis at term IV: the maternal plasma cytokine profile
Romero, R. J., Chaemsaithong, P., Docheva, N., Korzeniewski, S. J., Tarca, A. L., Bhatti, G., Xu, Z., Kusanovic, J. P., Dong, Z., Chaiyasit, N., et al. (2015) · Journal of Perinatal Medicine · doi:10.1515/jpm-2015-0103 · Cited by 80
Stock, A. T., Booth, S., & Cerundolo, V. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101967 · Cited by 73
“Mice with deletions in one of Ptger1 (EP-1), Ptger2 (EP-2), Ptger3 (EP-3), or Ptger4 (EP-4) were generated as previously described (Segi et al., 1998; Ushikubi et al., 1998; Hizaki et al., 1999).”
MethodSharma-Walia, N., Raghu, H., Sadagopan, S., Ramu, S., Veettil, M. V., Naranatt, P. P., Smith, M. M., & Chandran, B. (2006) · Journal of Virology · doi:10.1128/jvi.00231-06 · Cited by 71
“COX-2 produces an important inflammatory prostaglandin, prostaglandin E2 (PGE2), which is a potent immunoregulatory lipid mediator that plays key roles in the regulation of a number of cellular processes, including the acute and chronic inflammatory responses as well as innate immune responses which are generally prod…”
Background
Metadata
- Authors
- Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., Tanaka, T., Yoshida, N., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Osaka Women's and Children's Hospital (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1998-09
- Volume
- 395
- Issue
- 6699
- Pages
- 281-284
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647648618
- Cited by
- 677
- References
- 30
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 15 · 2020: 15 · 2019: 11 · 2018: 18 · 2017: 14 · 2016: 18 · 2015: 24 · 2014: 14 · 2013: 12 · 2012: 22
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- fever, prostaglandin E2, EP3 receptor, prostaglandin E receptors, IL-1β, lipopolysaccharide, exogenous pyrogens, endogenous pyrogen, receptor knockout mice, prostaglandin synthesis
- MeSH terms
- Animals, Crosses, Genetic, Fever, Interleukin-1, Lipopolysaccharides, Mice, Inbred C57BL, Pyrogens, Dinoprostone, Receptors, Prostaglandin E, Gene Targeting, Mice, Receptors, Prostaglandin E, EP3 Subtype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.